Pradaxa®
dabigatran etexilate
About Pradaxa®
Prevention of strokes and blood clots in patients with abnormal heart rhythm (atrial fibrillation).
Primary prevention of venous thrombo-embolic events (VTE) in adults after elective total hip or knee replacement surgery.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and secondary prevention of recurrent DVT and PE in adults.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Stroke prevention in atrial fibrillation Primary prevention of venous thromboembolic events after orthopaedic surgery Treatment and secondary prevention of venous thromboembolic events
Brand Names
Pradaxa® Pradaxar® Prazaxa®
Active ingredients
dabigatran etexilate